Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Biotechnology Product for Wound Healing More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Computerized decision making information system to direct the orders for patients sustaining multiple rib fractures. More
MRI contast medium More
MRI contast medium More
Injectable for treatment of PONV and nausea and vomiting during post-operative PCA More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 15 pages - $250
May 2011 - 15 pages - $250
Jun 2010 - 22 pages - $99
May 2011 - 15 pages - $250
Mar 2011 - 50 pages - $1,000
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adhesion
- Anesthesia
- Bleeding
- Cosmetic surgery
- Dialysis
- Disinfectant
- Fibrosis
- General surgery
- Infection control
- Infusion
- Injection
- Intravenous
- Irrigation
- Perfusion
- Plasma expander
- Plasma substitute
- Surgery (other)
- Tissue grafting
- Transplantation
- Wound closure
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us